CareCloud (CCLD) Stock Price, News & Analysis

Company Overview

CareCloud, Inc. is a healthcare technology company that provides cloud-based practice management, electronic health record (EHR) and revenue cycle management (RCM) solutions to medical practices and health systems. Its flagship offering, the CareCloud Central platform, combines clinical, financial and administrative workflows into a single, unified system. The platform includes modules for scheduling, billing, coding, patient engagement and telehealth, enabling practices to streamline front- and back-office operations and improve overall practice performance.

Founded in 2009 and headquartered in Miami Beach, Florida, CareCloud serves small to mid-size physician groups and specialty clinics across the United States. The company supports a broad range of specialties, including primary care, cardiology, orthopedics and behavioral health, among others. Over the years it has expanded its geographic reach through strategic partnerships and offshore support centers, while continuing to enhance its cloud-native technology with analytics, interoperability and patient engagement tools designed to meet evolving regulatory and clinical requirements.

CareCloud is led by founder and Chief Executive Officer Albert Santalo, a healthcare technology entrepreneur with extensive experience in digital health and practice automation. Under his leadership, the company has pursued both organic product development and targeted acquisitions to broaden its service offerings. CareCloud’s management team and board include healthcare, technology and finance veterans who drive the company’s mission to deliver scalable, data-driven solutions that help medical practices optimize revenue, reduce administrative burden and improve patient care.

Key Stats

• Today's Range: $2.09 to $2.23
• 50-Day Range: $2.11 to $3.81
• 52-Week Range: $1.96 to $4.01
• Volume: 980,240 shs
• Average Volume: 698,439 shs
• Market Capitalization: $93.05 million
• P/E Ratio: 19.91
• Dividend Yield: N/A
• Price Target: $3.25
• Consensus Rating: Hold

CareCloud Stock Analysis - MarketRank™

CareCloud scored higher than 86% of companies evaluated by MarketBeat, and ranked 78th out of 851 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Hold

Consensus Rating

CareCloud has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 1 buy rating, 2 hold ratings, and no sell ratings.

Upside Potential

CareCloud has a consensus price target of $3.25, representing about 48.4% upside from its current price of $2.19.

Amount of Analyst Coverage

CareCloud has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 26.32%

Earnings Growth

Earnings for CareCloud are expected to grow by 26.32% in the coming year, from $0.38 to $0.48 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of CareCloud is 19.91, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.39.

Price to Earnings Ratio vs. Sector

The P/E ratio of CareCloud is 19.91, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 20.79.

Price to Book Value per Share Ratio

CareCloud has a P/B Ratio of 1.60. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.42% of the float of CareCloud has been sold short.

Short Interest Ratio / Days to Cover

CareCloud has a short interest ratio ("days to cover") of 1.37, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in CareCloud has recently decreased by 5.01%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

CareCloud does not currently pay a dividend.

Dividend Growth

CareCloud does not have a long track record of dividend growth.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.40

News Sentiment

CareCloud has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for CareCloud this week, compared to 2 articles on an average week.

Search Interest

Only 4 people have searched for CCLD on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.

MarketBeat Follows

1 people have added CareCloud to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.6 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, CareCloud insiders have not sold or bought any company stock.

Percentage Held by Insiders

14.80% of the stock of CareCloud is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

10.16% of the stock of CareCloud is held by institutions.

Company Calendar

• Last Earnings: 5/07/2026
• Today: 5/19/2026
• Investor Day 2026: 5/19/2026
• Next Earnings (Estimated): 8/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MEDICAL INFO SYS
• Sub-Industry: Computer Software
• Current Symbol: NASDAQ:CCLD
• Previous Symbol: NASDAQ:MTBCP
• CIK: 1582982
• Web: www.carecloud.com
• Phone: (732) 873-5133
• Fax: 732-873-3378
• Employees: 3,650
• Year Founded: 2009

Price Target and Rating

• Average Price Target for CareCloud: $3.25
• High Price Target: $3.25
• Low Price Target: $3.25
• Potential Upside/Downside: +48.4%
• Consensus Rating: Hold
• Rating Score (0-4): 2.33
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.11
• Trailing P/E Ratio: 19.91
• Forward P/E Ratio: 5.76
• P/E Growth: N/A
• Net Income: $10.80 million
• Net Margins: 7.87%
• Pretax Margin: 8.04%
• Return on Equity: 24.05%
• Return on Assets: 16.38%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.11
• Quick Ratio: 1.09

Sales & Book Value

• Annual Sales: $120.50 million
• Price / Sales: 0.77
• Cash Flow: $0.71 per share
• Price / Cash Flow: 3.08
• Book Value: $1.37 per share
• Price / Book: 1.60

Miscellaneous

• Outstanding Shares: 42,490,000
• Free Float: 36,204,000
• Market Cap: $93.05 million
• Optionable: Optionable
• Beta: 1.60